Back
Neurogene Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
18
NGNE
Neurogene
Last Price:
24.63
Seasonality Move:
25.48%
Sell
25
DRUG
Bright Minds Biosciences
Last Price:
46.84
Seasonality Move:
-24.57%
Sell
18
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $24.57. The Score for NGNE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
25
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
- The current Bright Minds Biosciences [DRUG] share price is $46.55. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $46.55
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight selling pressure.
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -7.12 | Sell |
Relative Strength Index (14 RSI): | 38.07 | Sell |
Chaikin Money Flow: | -487776 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.56 - 58.04) | Sell |
Bollinger Bands (100): | (30.62 - 51.16) | Sell |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.95 | Buy |
Relative Strength Index (14 RSI): | 61.69 | Buy |
Chaikin Money Flow: | -16145 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.09 - 49.25) | Buy |
Bollinger Bands (100): | (-4.86 - 35.5) | Buy |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.03 | Buy |
20-day SMA: | 38.5 | Sell |
50-day SMA: | 43.11 | Sell |
200-day SMA: | 38.53 | Sell |
8-day EMA: | 25.38 | Sell |
20-day EMA: | 32.53 | Sell |
50-day EMA: | 38.97 | Sell |
200-day EMA: | 36.82 | Sell |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.35 | Buy |
20-day SMA: | 42.22 | Buy |
50-day SMA: | 29.51 | Buy |
200-day SMA: | 8.28 | Buy |
8-day EMA: | 40.89 | Buy |
20-day EMA: | 39.84 | Buy |
50-day EMA: | 31.67 | Buy |
200-day EMA: | 13.3 | Buy |
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Technical Analysis
Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |